In regard to the antiphospholipid syndrome, anti-cardiolipin antibodies (aCL) are the antiphospholipid antibodies most frequently associated with the development of SVT; in particular, IgG aCL can be identified in patients with Budd Chiari Syndrome and PVT [24,25]. This evidence concerns the gene ACLY and hepatic veno-occlusive disease.